| A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injury (NCT01140828) | Chinese University of Hong Kong | 2009-05-01 |
| Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) (NCT01075711) | Merck KGaA, Darmstadt, Germany | 2009-04-01 |
| Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan (NCT00687193) | Pfizer | 2009-03-01 |
| A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate (NCT00847613) | Pfizer | 2009-03-01 |
| A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis (NCT00814307) | Pfizer | 2009-02-01 |
| A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission (NCT00808509) | AbbVie (prior sponsor, Abbott) | 2009-01-01 |
| Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis (NCT00815906) | Pfizer | 2008-12-01 |
| Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis (NCT00867516) | CSL Behring | 2008-10-01 |
| A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT00718718) | Centocor, Inc. | 2008-08-11 |
| Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients (NCT00686868) | GlaxoSmithKline | 2008-06-13 |
| A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy (NCT00689728) | Eli Lilly and Company | 2008-06-01 |
| Phase IIIB Switching From Intravenous to Subcutaneous Study (NCT00663702) | Bristol-Myers Squibb | 2008-05-01 |
| Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate (NCT00628095) | Pfizer | 2008-04-07 |
| A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis (NCT00658047) | Chelsea Therapeutics | 2008-04-01 |
| Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis (NCT00674635) | GlaxoSmithKline | 2008-04-01 |
| Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis (NCT00634933) | Pfizer | 2008-03-01 |
| Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis (NCT00565409) | Pfizer | 2008-03-01 |
| A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate (NCT00620685) | Pfizer | 2008-03-01 |
| Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication (NCT00855322) | University College Dublin | 2008-01-01 |
| Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy (NCT00603525) | GlaxoSmithKline | 2008-01-01 |
| Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403 (NCT00655824) | GlaxoSmithKline | 2008-01-01 |
| Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis (NCT00596206) | Sanofi | 2007-12-01 |
| A Phase I Rheumatoid Arthritis Study in Healthy Volunteers (NCT00539760) | GlaxoSmithKline | 2007-09-05 |
| Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) (NCT00660647) | University of Aarhus | 2007-09-01 |
| A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis (NCT00550446) | Pfizer | 2007-09-01 |
| Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis (NCT00760968) | Takeda | 2007-08-01 |
| Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT00550355) | Pfizer | 2007-08-01 |
| An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis (NCT00896168) | Xian-Janssen Pharmaceutical Ltd. | 2007-06-01 |
| An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants (NCT00760669) | Janssen Korea, Ltd., Korea | 2007-05-01 |
| Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550 (NCT00414661) | Pfizer | 2007-04-01 |
| Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis (NCT00446784) | Pfizer | 2007-04-01 |
| Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life (NCT00619177) | Boehringer Ingelheim | 2007-03-01 |
| Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis (NCT00413699) | Pfizer | 2007-02-05 |
| Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA (NCT00418717) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-02-01 |
| Maraviroc in Rheumatoid Arthritis (NCT00427934) | Pfizer | 2007-02-01 |
| Hanyang University Medical Center Arthritis Network (NCT00418405) | Hanyang University | 2007-01-01 |
| C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France (NCT02886689) | Central Hospital, Nancy, France | 2007-01-01 |
| Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis (NCT00413660) | Pfizer | 2007-01-01 |
| An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis (NCT00383188) | Pfizer | 2006-12-15 |
| Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis (NCT00440492) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Non Alcoholic Fatty Liver Disease in Rheumatoid Arthritis (NCT00394238) | Shaare Zedek Medical Center | 2006-11-01 |
| A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis (NCT00393146) | GlaxoSmithKline | 2006-10-01 |
| A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose (NCT00439881) | GlaxoSmithKline | 2006-10-01 |
| Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients (NCT00749645) | Juan C. Bertoglio, MD | 2006-10-01 |
| The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED) (NCT00748930) | Merck Sharp & Dohme LLC | 2006-09-01 |
| A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED) (NCT00732875) | Merck Sharp & Dohme LLC | 2006-08-01 |
| Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis (NCT00445770) | Pfizer | 2006-07-01 |
| A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis (NCT00424294) | Pfizer | 2006-06-01 |
| Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis (NCT00443950) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-06-01 |
| A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis (NCT00308282) | Eli Lilly and Company | 2006-03-28 |
| Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis (NCT00273858) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (NCT00727298) | Merck Sharp & Dohme LLC | 2006-02-01 |
| A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s) (NCT00299546) | Centocor, Inc. | 2006-02-01 |
| A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. (NCT00379990) | GlaxoSmithKline | 2006-01-01 |
| A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis (NCT00281294) | PDL BioPharma, Inc. | 2005-12-01 |
| A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis (NCT00380744) | Eli Lilly and Company | 2005-11-01 |
| Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) (NCT00256919) | GlaxoSmithKline | 2005-11-01 |
| SB-681323 In Subjects With Rheumatoid Arthritis (NCT00320450) | GlaxoSmithKline | 2005-11-01 |
| Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis (NCT00141102) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-10-01 |
| Remicade Infusion Management Program (NCT00723905) | Janssen Inc. | 2005-08-01 |
| Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA) (NCT00370435) | GlaxoSmithKline | 2005-08-01 |
| Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects (NCT00126724) | Targeted Genetics Corporation | 2005-08-01 |
| A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis (NCT00134693) | GlaxoSmithKline | 2005-06-21 |
| A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED) (NCT00202852) | Merck Sharp & Dohme LLC | 2005-06-01 |
| COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis (NCT00113308) | GlaxoSmithKline | 2005-06-01 |
| SB-681323-Methotrexate Interaction Study (NCT00419809) | GlaxoSmithKline | 2005-05-01 |
| Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis (NCT00185848) | Sanjiv Sam Gambhir | 2005-04-01 |
| Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients (NCT00124449) | Bristol-Myers Squibb | 2005-02-01 |
| HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II (NCT00291928) | GlaxoSmithKline | 2005-02-01 |
| Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study (NCT00289133) | DePuy Orthopaedics | 2005-02-01 |
| The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis (NCT00379600) | GlaxoSmithKline | 2004-11-01 |
| Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis (NCT00096759) | National Center for Complementary and Integrative Health (NCCIH) | 2004-11-01 |
| 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003) (NCT00543465) | Merck Sharp & Dohme LLC | 2004-08-01 |
| Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis (NCT00760864) | Takeda | 2004-08-01 |
| A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis (NCT00239382) | Boehringer Ingelheim | 2004-07-01 |
| SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate (NCT00089921) | Scios, Inc. | 2004-07-01 |
| Ramipril in Rheumatoid Arthritis (NCT00273533) | University of Zurich | 2004-06-01 |
| Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008) (NCT00542022) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Leflunomide in Rheumatoid Arthritis (NCT00280644) | Sanofi | 2004-04-01 |
| Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study (NCT00612885) | Boehringer Ingelheim | 2004-03-01 |
| Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis (NCT00367965) | Sumitomo Pharma America, Inc. | 2004-02-01 |
| Effects Of Prednisolone On Rheumatoid Arthritis Patients (NCT00330889) | GlaxoSmithKline | 2004-02-01 |
| Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases (NCT02184065) | Boehringer Ingelheim | 2004-01-01 |
| APART Advanced Profiling of Anti-Rheumatic Therapies (NCT00378261) | Centocor Ortho Biotech Services, L.L.C. | 2004-01-01 |
| A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) (NCT00071812) | Human Genome Sciences Inc. | 2003-12-01 |
| Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand (NCT00124254) | University of Michigan | 2003-09-01 |
| Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027) (NCT00794898) | Merck Sharp & Dohme LLC | 2003-07-01 |
| Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain (NCT00195377) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-04-01 |
| Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients (NCT00650455) | Pfizer | 2003-02-01 |
| Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis (NCT00544154) | UCB Pharma | 2002-10-01 |
| Remicade Safety Line (Study P03236)(COMPLETED) (NCT00748826) | Merck Sharp & Dohme LLC | 2002-08-01 |
| A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis (NCT00042068) | Boehringer Ingelheim | 2002-06-01 |
| Objective Study in Rheumatoid Arthritis (NCT00451971) | Sanofi | 2002-03-01 |
| Biologic Treatment Registry Across Canada (NCT00741793) | Janssen Inc. | 2002-02-12 |
| Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen (NCT00145730) | The George Institute | 2002-02-01 |
| A Long-term Safety Study of Infliximab (Remicade) (NCT00261976) | Centocor, Inc. | 2002-02-01 |
| The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol (NCT00246064) | Centocor Ortho Biotech Services, L.L.C. | 2001-12-01 |
| Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome (NCT02180516) | Boehringer Ingelheim | 2001-10-01 |
| Atherosclerosis in Rheumatoid Arthritis (NCT00037336) | Vanderbilt University | 2001-09-01 |
| Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome (NCT00025818) | Allergan | 2001-05-01 |